Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome.
about
The behavior of matrix metalloproteinases and their inhibitors in colorectal cancerCo-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor MicroenvironmentLack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer.Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice.Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasionHigh serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysisThe role of inflammation and proteinases in tumor progression.Impact of proteolytic enzymes in colorectal cancer development and progression.Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer.Nonselective matrix metalloproteinase but not tumor necrosis factor-α inhibition effectively preserves the early critical colon anastomotic integrity.Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysisHuman mast cells promote colon cancer growth via bidirectional crosstalk: studies in 2D and 3D coculture modelsThe Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases
P2860
Q27004958-B16BB565-C1A2-412C-8A81-FE3B32C631BBQ28552528-1DD1BCAA-AB6C-4632-868D-3457B7C9BAE0Q34502296-6B20BA0C-892D-4452-99DE-C07E0E97A422Q34526929-4F40F4F8-2DF8-4419-AF18-236EC15660EAQ35608684-CC9DDF29-10E6-40DB-BAE3-0D947F4674DFQ35743041-65F383DE-93DD-4EB2-AABC-5080A31739D6Q35834339-2F20ADF8-0F03-4EFD-8BB8-D2C9AC2702C8Q37109786-E53D024C-9F9F-42AF-9D59-D1C05C5F917EQ38020728-D83BC098-F025-4C38-9FE0-513E550232BFQ38259533-97E65D8F-7036-4E01-9A46-E45408590CB3Q47925738-478A75F8-5F5D-44CE-A464-59DB047B9A27Q54623334-2C4B86CA-74DA-4C93-8404-32389939B2C6Q56530637-CA36DF89-1561-4BF7-8BB1-5BD45CBC1162Q58129602-9D912CD2-14BA-411D-AAAA-294FA06371F1Q58427369-2B2B022B-C59D-4A42-BFD3-2946E061B4D5
P2860
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Expression of matrix metallopr ...... athology and patients outcome.
@en
type
label
Expression of matrix metallopr ...... athology and patients outcome.
@en
prefLabel
Expression of matrix metallopr ...... athology and patients outcome.
@en
P2093
P1476
Expression of matrix metallopr ...... athology and patients outcome.
@en
P2093
Annette Bartels
Ben Vainer
Jens Benn Sørensen
Nils Brünner
Søren Astrup Jensen
P304
P356
10.1016/J.EJCA.2010.07.046
P577
2010-12-01T00:00:00Z